Sudeep Pharma debuted strongly on D-Street with nearly 24% listing gains, aligning with grey market expectations. The Rs 895-crore IPO saw robust demand, subscribing 93.71 times. Strong institutional interest, solid financials, high margins, and leadership in specialised ingredients underpin investor confidence as the stock begins trading on the secondary market.Read More

Patel Engineering shares fell nearly 5% to Rs 35.58 on Friday after a sharp two-day rally. The stock had surged nearly 20% earlier in the week following the award of coal excavation and transportation contracts worth Rs 798.19 crore for the Jhiria West OCP in Chhattisgarh by SECL, with a nine-year execution period.Read More

In the Nifty500 pack, 10 stocks saw their closing prices fall below their 200-day moving average (200 DMA) on November 27, according to technical scan data from StockEdge.Read More

Indian markets hit fresh all-time highs as improving earnings, GST cuts, and easing macro pressures boost investor confidence. Quantum Advisors’ Nilesh Shetty says the worst of earnings downgrades is over, with banks, IT and insurance offering strong value. Industrial and FMCG stocks may lag, while an India–US tariff deal could trigger the next big market...Read More

Futures open interest surged over 10% in five NSE F&O stocks, signalling fresh positions and heightened market participation.Read More

On November 27, four stocks in the Nifty500 that gained over 3% appeared in the RSI Trending Up scan, according to data from StockEdge.Read More

Zydus Lifesciences is set to be in focus after it received tentative approval from the United States Food and Drug Administration for Empagliflozin and Linagliptin combination tablets for type 2 diabetes, alongside final approval for a blood pressure treatment drug. The company also entered into a licensing and commercialisation pact with RK Pharma for a...Read More

Indian government bonds are poised for a flat to slightly lower opening as traders anticipate a significant debt auction today, followed by crucial economic growth figures. The benchmark 10-year yield is expected to trade within a narrow band.Read More

Emcure Pharmaceuticals’ shares could see action following a Goods and Services Tax search at its Mumbai offices. The inspection concluded this week. The company recently reported a robust rise in revenue and profit after tax. Domestic and international businesses both showed strong performance.Read More

A 5-year swing high marks the highest price a stock has reached in the past five years and often acts as a significant resistance level.Read More